KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astrana Health (ASTH) Other Accumulated Expenses (2018 - 2025)

Astrana Health's Other Accumulated Expenses history spans 10 years, with the latest figure at $29.8 million for Q2 2025.

  • For Q2 2025, Other Accumulated Expenses fell 80.3% year-over-year to $29.8 million; the TTM value through Jun 2025 reached $29.8 million, down 80.3%, while the annual FY2024 figure was $209.0 million, 95.99% up from the prior year.
  • Other Accumulated Expenses for Q2 2025 was $29.8 million at Astrana Health, up from $28.2 million in the prior quarter.
  • Across five years, Other Accumulated Expenses topped out at $209.0 million in Q4 2024 and bottomed at $14.5 million in Q3 2024.
  • The 5-year median for Other Accumulated Expenses is $95.3 million (2022), against an average of $87.0 million.
  • The largest annual shift saw Other Accumulated Expenses skyrocketed 121.32% in 2022 before it crashed 85.17% in 2024.
  • A 5-year view of Other Accumulated Expenses shows it stood at $55.8 million in 2021, then soared by 45.66% to $81.3 million in 2022, then soared by 31.26% to $106.7 million in 2023, then soared by 95.99% to $209.0 million in 2024, then tumbled by 85.72% to $29.8 million in 2025.
  • Per Business Quant, the three most recent readings for ASTH's Other Accumulated Expenses are $29.8 million (Q2 2025), $28.2 million (Q1 2025), and $209.0 million (Q4 2024).